- India’s Pharma Industry upbeat as China removes import duty on 28 Indian drugs
- Finolex family spat, Board meet raise legal quandary
- Lanco infratech likely to face liquidation
- Flipkart buys shares from minority shareholders
- Xiaomi to file world’s biggest IPO since Alibaba’s 2014 debut
- New system may take a year for GST simplified forms
- PFRDA okays partial NPS fund withdrawal for education, business
- Jaypee bid: Lenders may not approve Lakshadweep’s offer
- HCC Stock dives 25 % : Auditors question Lavasa as going concern
- Bharti-Telenor merger: DoT moves SC against TDSAT’s relief on dues
- Our game plan for boosting sales starts with the new Amaze”—Honda Cars CEO
- Tesla cash burn accelerates, CEO predicts profit ahead
- VW’s CEO takes charge, says will focus on ethical culture
- US trade deficit down to $ 49 Bn due to record exports
- Tencent-backed internet giant probes massive user-data leak
- Govt may not buy Softbank’s $ 1 Tr power carrot
- Bharti Airtel may sell 25 % in Africa unit to raise up to $ 1.5 Bn
- IndiGo shares crash 18 % on poor Q 4 No.
- Bank deposits’ growth falls to 5 decade low
- Rupee falls Vs Yuan: Indian Exporters to gain
- Coke to launch nutrition drinks-electrolyte drinks
- Fortis, SRL to help in Global play : Malaysian IHH MD
- ISRO plans to put together a team for small rockets-low weight satellites
- Indian Internet cos. Grappling with fraud Apps installations, false claims, fake click
- Glenmark drug test under lens Osteo-pain medication
- New defence panel focuses on reforms : National security strategy on focus
- L& T Finance holdings put up good show : ROE 15% up, PAT Up by 40 %
- Vedanta too posts good results : Revenue and PAT up.
- E2E networking with NSE Emerge listing subscribed by 40 % on day 1
- Truebil crosses Rs 100 cr annualised revenue mark
- AI finds basis of Baby blindness : Facebook’s tool to flag phishing
- PNB Housing Revenue up and PAT up in Q4
- Production grows up @ 7.1 % ; Inflation dips 4.28 %
- Vedanta to complete ESL, Buyout in next Few weeks
